Fiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement Post author:GHIAA Admin Post published:November 5, 2021 Post category: Continue ReadingFiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
UK Secretary of State – AstraZeneca, COVID-19 Vaccine Supply Agreement Post author:GHIAA Editor Post published:May 28, 2021 Post category: Continue ReadingUK Secretary of State – AstraZeneca, COVID-19 Vaccine Supply Agreement
European Commission – AstraZeneca, COVID-19 Vaccine Advance Purchase Agreement Post author:GHIAA Admin Post published:March 12, 2021 Post category: Continue ReadingEuropean Commission – AstraZeneca, COVID-19 Vaccine Advance Purchase Agreement
European Commission – AstraZeneca, COVID-19 Vaccine Advance Purchase Agreement Post author:GHIAA Admin Post published:March 12, 2021 Post category: Continue ReadingEuropean Commission – AstraZeneca, COVID-19 Vaccine Advance Purchase Agreement
Merck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement Post author:GHIAA Editor Post published:May 22, 2020 Post category: Continue ReadingMerck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
BMS – MPP, Hepatitis C Antiviral (daclatasvir – DAC) License & Tech Transfer Agreement Post author:GHIAA Editor Post published:May 22, 2020 Post category: Continue ReadingBMS – MPP, Hepatitis C Antiviral (daclatasvir – DAC) License & Tech Transfer Agreement